MedCity News November 21, 2024
Experts aren’t sure what the outcome of the DOJ’s recent lawsuit against the proposed UnitedHealth Group/Amedisys merger will be under the incoming Trump administration. The Biden administration has focused more on supporting clinicians, while the previous Trump administration favored corporations. Additionally, one expert noted that this case differs from other antitrust lawsuits because it does not seem to focus on a potential price increase.
Yet another shoe has dropped in the UnitedHealth Group/Amedisys saga. Last week, the Justice Department — along with the Attorneys General of Maryland, Illinois, New Jersey, and New York — filed a lawsuit to block UHG’s $3.3 billion acquisition of home health and hospice company Amedisys through Optum.
In 2023, UnitedHealth Group’s Optum announced that it...
Today's Sponsors
Today's Sponsor